US FDA nod for 12-month labelling update for collagen-based facial filler Evolence
Wednesday, June 10, 2009 15:00 IST Herzliya, Israel
Ortho Dermatologics announced that the US Food and Drug Administration (FDA) approved a labelling supplement which includes efficacy and safety data through 12 months for Evolence
